Neck dissection for oral mucosal melanoma: Caution of nodular lesion

Oral Oncology

Volumn 50, Issue 4, 2014, Pages 319-324

  Wu, Yunteng ^a   Zhong, Yi ^b   Li, Chaojun ^a   Song, Hao ^a   Guo, Wei ^a   Ren, Guoxin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Melanoma; Neck dissection; Nodular; Oral; Prognosis

Indexed keywords

CDDP; CISPLATIN; DACARBAZINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER PROGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; MOUTH TUMOR; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; NECK TUMOR; ORAL MUCOSAL MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; YOUNG ADULT;

MELANOMA; NECK DISSECTION; NODULAR; ORAL; PROGNOSIS;

ADULT; AGED; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOUTH MUCOSA;

EID: 84895463303     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.01.008     Document Type: Article

References (34)

1. A.M. Sortino-Rachou, Mde C. Cancela, L. Voti, and M.P. Curado Primary oral melanoma: population based incidence Oral Oncol 45 2009 254 258
2. A.E. Chang, L.H. Karnell, and H.R. Menck The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society Cancer 83 1998 1664 1678
3. M. Umeda, and K. Shimada Primary malignant melanoma of the oral cavity-its histological classification and treatment Br J Oral Maxillofac Surg 32 1994 39 47
4. S. Manolidis, and P.J. Donald Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients Cancer 80 1997 1373 1386
5. M. Meleti, C.R. Leemans, and R. de Bree et al. Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy Head Neck 30 2008 1543 1551
6. T. Tanaka, R. Yamada, and M. Tanaka et al. A study on the image diagnosis of melanoma Conf Proc IEEE Eng Med Biol Soc 3 2004 1597 1600
7. R.I. van der Waal, G.B. Snow, A.B. Karim, and I. van der Waal Primary malignant melanoma of the oral cavity: a review of eight cases Br Dent J 176 1994 185 188
8. S.G. Patel, M.L. Prasad, and M. Escrig et al. Primary mucosal malignant melanoma of the head and neck Head Neck 24 2002 247 257
9. R.C. Chan, J.Y. Chan, and W.I. Wei Mucosal melanoma of the head and neck: 32-year experience in a tertiary referral hospital Laryngoscope 122 2012 2749 2753
10. N. Tanaka, T. Amagasa, and H. Iwaki et al. Oral malignant melanoma in Japan Oral Surg Oral Med Oral Pathol 78 1994 81 90
11. X. Wang, H.M. Wu, and G.X. Ren et al. Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient J Oral Maxillofac Surg 70 2012 1192 1198
12. X. Yang, G.X. Ren, and C.P. Zhang et al. Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma BMC Cancer 10 2010 623
13. N. Tanaka, M. Mimura, K. Ogi, and T. Amagasa Primary malignant melanoma of the oral cavity: assessment of outcome from the clinical records of 35 patients Int J Oral Maxillofac Surg 33 2004 761 765
14. S.J. Blatchford, C.F. Koopmann Jr., and S.W. Coulthard Mucosal melanoma of the head and neck Laryngoscope 96 1986 929 934
15. F.K. Storm 3rd, F.R. Eilber, D.L. Morton, and W.H. Clark Jr. Malignant melanoma of the head and neck Head Neck Surg 1 1978 123 128
16. N. McLean, M. Tighiouart, and S. Muller Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma Oral Oncol 44 2008 1039 1046
17. M. Krengli, L. Masini, and J.H. Kaanders et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A rare cancer network study Int J Radiat Oncol Biol Phys 65 2006 751 759
18. D.G. Pfister, K.K. Ang, and D.M. Brizel et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines J Natl Compr Cancer Network 11 2013 917 923
19. V. Mar, H. Roberts, and R. Wolfe et al. Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia J Am Acad Dermatol 68 2013 568 575
20. M.F. Demierre, C. Chung, D.R. Miller, and A.C. Geller Early detection of thick melanomas in the United States: beware of the nodular subtype Arch Dermatol 141 2005 745 750
21. W.R. Shaikh, M. Xiong, and M.A. Weinstock The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007 Arch Dermatol 148 2012 30 36
22. D.L. Morton, J.F. Thompson, and A.J. Cochran et al. Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 2006 1307 1317
23. N. Mozzillo, E. Pennacchioli, and S. Gandini et al. Sentinel node biopsy in thin and thick melanoma Annu Surg Oncol 20 2013 2780 2786
24. A.J. Dixon Is sentinel node biopsy in melanoma a test or a treatment? BMJ 346 2013 f677
25. I. Starek, P. Koranda, and P. Benes Sentinel lymph node biopsy: a new perspective in head and neck mucosal melanoma? Melanoma Res 16 2006 423 427
26. S. Temam, G. Mamelle, and P. Marandas et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck Cancer 103 2005 313 319
27. R. Mouawad, M. Sebert, and J. Michels et al. Treatment for metastatic malignant melanoma: old drugs and new strategies Crit Rev Oncol Hematol 74 2010 27 39
28. M.B. Atkins The treatment of metastatic melanoma with chemotherapy and biologics Curr Opin Oncol 9 1997 205 213
29. G. Cocconi High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma Cancer 70 1992 902
30. J.R. Murren, W. DeRosa, and H.J. Durivage et al. High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma Cancer 67 1991 1514 1517
31. M.S. Harting, and K.B. Kim Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma Melanoma Res 14 2004 517 520
32. K. Young, A. Minchom, and J. Larkin BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF(V600E) mutation Future Oncol 8 2012 499 507
33. P.B. Chapman, A. Hauschild, and C. Robert et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 364 2011 2507 2516
34. J. Guo, L. Si, and Y. Kong et al. Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification J Clin Oncol 29 2011 2904 2909